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Clinical predictors of outcome in acute upper gastro-
intestinal bleeding 
S Z Kalula, G H Swingler, J A Louw 
Objective. Endoscopy has traditionally been used to risk-
stratify patients with upper gastrointestinal bleeding (UGIB). 
This is problematic in resource-poor environments. The study 
aimed to identify patients who would not require urgent 
endoscopy by identifying clinical variables before endoscopy 
that predict uneventful recovery. 
Design. Prospective, descriptive cross-sectional study. 
Setting. Groote Schuur Hospital, Cape Town. 
Subjects. Two hundred consecutive patients aged over 12 
years, presenting with haematemesis and/ or melaena. 
Outcome measures. Good outcome, i.e. no blood transfusion, 
endotherapy or surgery, and alive at 1 month following 
presentation. 
Results. Eighty patients (40%) had a good outcome. 
Haemoglobin > 10 g/dl (odds ratio (OR) 25.5, 95% 
confidence interval (CI): 8.9- 74.8; p < 0.001), absence of 
melaena (OR 4.8, 95% CI: 1.79- 12.94, p;::: 0.002) and absence 
of syncope (OR 4.0, 95% CI: 1.67- 9.48; p = 0.002) were 
Acute upper gastrointestinal bleeding (UGIB) is a common 
cause of emergency hospital admission and is associated with 
substantial health expenditure.1 The condition is also not 
uncommon among already-hospitalised patients. 
Despite improved technology in the management of UGIB, 
mortality has remained high. This has been attributed to the 
increase in the population of elderly people who tend to have 
other underlying diseases leading to the high mortality rate. 
According to international literature, mortality varies from 4% 
to 10%.2,3 The bulk of severe morbidity and mortality occurs in 
patients with recurrent bleeding or significant co-morbid 
illness.' 
The use of non-steroidal anti-inflammatory drugs (NSAIDs), 
common in the elderly, more than doubles mortality associated 
with peptic ulcer complications.' 
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independent predictors of good outcome. The three variables 
combined as a positive test had the best association with 
good outcome when compared with a single variable or a 
combination of two variables. The three-variable model had 
sensitivity for good outcome of 34%, specificity of 98%, and 
likelihood ratio for a positive test of 13.5 and for a negative 
testof 0.68. Thirty patients (15%) had the combination for the 
prediction rule, i.e. haemoglobin > 10 g/ dl, no melaena and 
no syncope; 3 (10%) had a poor outcome (required 
endotherapy). 
Conclusion. The prediction rule accurately excluded poor 
outcome, a priority in the clinical context, but did not predict 
good outcome. Clinical implications are a 15% reduction in 
unnecessary urgent endoscopies, with less than 5% of 
patients with poor outcome not undergoing urgent 
endoscopy. These findings may have particular clinical 
relevance in under-resourced health care environments. 
S Afr Med J 2003; 93: 286-290. 
Endoscopy has traditionally been used to risk-stratify 
patients with UGIB.' This approach may be inappropriate in 
large areas of South Africa where endoscopy is not readily 
available. Ideally, to avoid waste of limited resources and time, 
it would be helpful to identify patients in whom endoscopy 
could be delayed without deleterious outcome, reserving 
emergency endoscopy for patients at highest risk for both re-
bleeding, morbidity and mortality. In this class of patients 
endoscopy is used not only for diagnosis but also for 
endoscopic treatment to control massive ulcer bleeding. 
From the time that research and debate on factors 
influencing the outcome of acute upper gastro-intestinal 
haemorrhage began, age, co-morbidity, shock, admission 
haemoglobin values, presentation (either with haematemesis, 
melaena or both), ulcer type, ulcer size, stigmata of recent 
haemorrhage (visible vessel in an ulcer bed, ooze, fresh clot) 
and transfusion requirement have all been described as 
significant risk factors for further haemorrhage and death.7 
However, there is no universal agreement on a set of risk 
factors as researchers have emphasised different factors 
according to their experience and have used different 
endpoints.' 
Until recently, no study had attempted to devise a simple 
and therefore clinically useful risk scoring system that would 
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be readily available to the clinician for categorising patients by 
risk. Of the studies that have investigated predictors of 
outcome, a large number have looked at predictors of adverse 
outcome (re-bleed, death and surgery). Very few studies have 
looked at predictors of good outcome. Even then, most of these 
studies have included endoscopic findings in their decision 
criteria. 6'8 
Does a predictor of good outcome equal the absence of a 
predictor of poor outcome? It is not possible to implement the 
opposite of predictors of adverse outcome as being predictors 
of good outcome, as endpoints in the studies would be 
different. For example, factors that predict mortality, such as 
age and co-morbidity, are not necessarily predictive of 
persistent or recurrent bleeding.' 
Of principal concern is the safety of patients who would be 
discharged from primary and secondary health care facilities 
for deferred endoscopy examination. There is a need to isolate 
those predictors of good outcome able to classify patients who 
could be safely discharged on medical therapy without prior 
endoscopy and recover without any adverse event. The 
decision rule would be used only to delay (urgent) endoscopy; 
a diagnostic endoscopy would still be done. Diagnostic 
endoscopy without a therapeutic procedure does not alter 
mortality, although in most cases it provides information on 
the source of bleeding. 
Given the scarcity of information on the non-endoscopic 
triage of patients, a prospective study of patients with acute 
upper gastro-intestinal haemorrhage was undertaken to 
identify patients at low risk for an adverse outcome following 
acute UGIB at Groote Schuur Hospital in Cape Town. 
Study population and methods 
Consecutive patients over the age of 12 years presenting to the 
Emergency Unit with haematemesis and/or melaena between 
October 1997 and August 1998, were prospectively studied. 
Patients were excluded if: (i) their initial presentation was to 
another hospital that instituted resuscitative measures; (ii) they 
were known to have oesophageal varices or upper gastro-
intestinal malignancy; (iii) they presented with anaemia 
without a clear history of UGIB; or (iv) if they developed UGIB 
during the course of hospitalisation for another problem. 
Data were collected using a structured clerking sheet 
designed for the study; which included demographic 
characteristics; mode of presentation, i.e. haematemesis and/ or 
melaena; history of pre-syncope (near fainting or extreme 
dizziness) or syncope (transient loss of consciousness with loss 
of postural tone); medication use, particularly non-steroidal 
anti-inflammatory drugs (NSAIDs), salicylates or warfarin; 
alcohol use; history of previous peptic ulcer disease; 
haemoglobin concentration; pulse; systolic blood pressure 
(SBP); postural hypotension; and co-morbidity. Each patient 
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underwent endoscopic examination. 
The criteria for a good outcome were: (i) non-performance of 
an endoscopic procedure (endotherapy) to control bleeding, a 
therapeutic surgical procedure, or a blood or blood product 
transfusion; and (ii) alive within 1 month of initial presentation. 
Patients were followed up at 1 month after hospital discharge. 
Blood transfusion was taken to be a poor-outcome event 
because of the laboratory, medical and nursing expertise 
required in its administration, as well as being an indicator of 
significant bleeding. Endotherapy and surgery were regarded 
as poor-outcome criteria because these services require trained 
specialists who are only available at some secondary level 
hospitals and at no primary level hospitals. Hence all patients 
with UGIB requiring such interventions need to be referred to 
centres where these facilities are available. Death is the end-
point that we all strive to reduce. 
Data analysis 
Data were entered into a standard spreadsheet (Excel), and 
univariate, bivariate and multivariate descriptive statistics 
were derived using Statistica Version 5.1 (1998) software. 
Bivariate analysis for individual predictive factors of good 
outcome was performed using the chi-square test. Continuous 
variables were compared using the unpaired Hest. To increase 
clinical relevance the continuous variables were converted into 
categorical variables using internationally acceptable ranges 
defining severity of an UGIB. Statistical significance was 
accepted at p < 0.05 (two-tailed). 
Clinical predictors that showed significant association with 
good outcome on bivariate analysis were entered into a 
multiple logistical regression modeL A final model was selected 
using stepwise multiple logistical regression analyses. 
Sensitivity, specificity, positive predictive value, negative 
predictive value, likelihood ratio (LR) for a positive test and LR 
for a negative test were calculated individually and in 
combination for variables that were found to be independently 
associated with outcome. 
LRs are measures of the accuracy with which a diagnostic 
test identifies its target disorder in an individual patient. They 
are regarded as the most useful indicators of test accuracy in a 
clinical context involving individual patients. The higher the 
ratio is above 1, the greater the change in probability in favour 
of the condition of interest; the lower the ratio below 1, the 
greater the change in probability against the condition of 
interest.10 
ll:r.!:'JI.· The investigators pre-specified a predictive tool with a atM 
specificity of not less than 95% as an acceptable benchmark, i.e. 





The study was approved by the Ethics and Research 
Committee of the Faculty of Health Sciences, University of 
CapeTown. 
Results 
Over the 10-month study period, a total of 306 patients were 
admitted to the Emergency Unit with a diagnosis of haemate-
mesis and/or melaena. A total of 200 of these patients (65.4%) 
met the inclusion criteria and were included in the final 
analysis. 
The median age of the 200 patients was 57.5 years (range 19-
93 years). One hundred and twenty-two patients (61 %) were 
males and 78 (39%) were females. 
One hundred and two of the patients (51%) had blood 
transfusions with 11 (5.5%) requiring more than five units of 
blood. Thirty-five (17.5%) had endoscopic therapy, and 8 (4%) 
underwent surgery. There were 13 deaths (6.5%), of which 8 
deaths were related to gastrointestinal haemorrhage, while 5 
were related to other underlying co-morbidity. Bleeding-related 
mortality was 4% and mortality due to underlying co-
morbidity was 2.5%. Of the 200 patients, 80 (40%) had a good 
outcome (no transfusion, endotherapy or surgery, and alive at 1 
month after presentation). 
On bivariate analysis, age, pulse, SBP, haemoglobin, history 
of pre-syncope or syncope (syncope), anticoagulant use, 
presentation with either melaena or haematemesis, and co-
morbidity were significant predictors of outcome. Variables not 
associated with outcome were use of NSAIDs, salicylates, 
alcohol and history of previous peptic ulcer disease (Table I). 
Table I. Predictors of good outcome (no transfusion, endoscopic 
therapy or surgery, and alive at 1 month) (bivariate logistical 
regression analysis) 
RR 95%Cl forRR P-value 
Age < 60 years 1.58 1.10-2.28 0.01 
Pulse < 100 beats I min 1.76 1.18-2.60 0.003 
SBP > 100 mmHg 4.58 1.20-17.30 0.002 
Hb> 10g/dl 10.50 4.80-23.0 < 0.001 
Syncope 0.43 0.29-0.62 < 0.0001 
Warfarin 1.67 1.28-2.19 0.006 
Co-morbidity 0.67 0.48-0.94 0.02 
Haematemesis 1.72 1.14- 2.59 0.005 
Melaena 0.58 0.39-0.88 0.005 
NSAIDs/ salicylates 0.82 0.58-1.17 0.26 
Alcohol 1.27 0.86-1.88 0.25 
Previous PUD 0.90 0.62-1.32 0.59 
RR = relative risk; CI = confidence interval; SBP = systolic blood pressure; Hb = 
haemoglobin; NSA!Ds = non·steroidal anti-inflammatories; PUD = peptic ulcer 
disease. 
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Although not predictive of outcome, current intake of 
salicylates or NSAIDs was significantly associated with the 
diagnosis of peptic ulcer disease on endoscopy (relative risk 
(RR) 1.79, 95% confidence interval (CI): 1.33- 2.40, p < 0.001). 
On multiple logistical regression analysis, absence of 
melaena, absence of history of pre-syncope or syncope, and 
haemoglobin value greater that 10 g/ dl were independent 
predictors of good outcome (Table II). These three variables 
were included in the final model selected (Table III). 
Table II. Predictors of good outcome (no transfusion, endoscopic 
therapy or surgery, and alive at 1 month) (multiple logistical 
regression analysis) 






Pulse< 100 beats/min 
SBP > 100 mmHg 
Age < 60 years 
No co-morbidity 
5.21 1.36 - 19.93 0.01 
0.96 0.29-3.10 0.95 
3.80 1.44-10.09 0.006 
0.76 0.11-5.25 0.78 
22.97 6.85-76.98 < 0.0001 
2.37 0.78-7.10 0.12 
2.48 0.34-18.01 0.36 
1.09 0.36-3.35 0.87 
1.03 0.34-3.14 0.95 
Cl = confidence interval; Hb = haemoglobin; SBP= systolic blood pressure. 








Cl = confidence interval; Hb = haemoglobin. 







The selected model had sensitivity for good outcome of 34% 
(95% Cl: 27- 40%), specificity of 98% (95- 100%), positive 
predictive value of 90% (86- 94%) and negative predictive 
value of 69% (62- 75%). The likelihood ratio for a positive 
(LR+) test was 13.5 (5.3- 54.0) and the likelihood ratio for a 
negative (LR-) test was 0.68 (0.57- 0.79). In this study, using 
this model, 72% of patients were correctly classified. 
A model taking any two of the three variables as a positive 
test had lower specificity of 83% (78- 88%), and lower LR+ 
of 4.4. 
Discussion 
This prospective study was undertaken to define predictors of 
good outcome (i.e. no transfusion, endotherapy or surgery, and 
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alive at 1 month) in patients presenting with acute UGIB, with 
a view to identifying criteria for the selection of patients who 
would recover uneventfully without need for urgent 
endoscopy. 
Eighty of the patients (40%) had a good outcome. One 
hundred and two (51%) had blood transfusion, 35 (17.5%) had 
endotherapy and 8 (4%) underwent surgery. The total mortality 
of 6.5% was within the range of most other studies. The main 
finding of the study was that absence of melaena, the absence 
of syncope and haemoglobin greater than 10 g/ dl were 
predictors of good outcome, as pre-defined. 
Some of the findings warrant comment: 
1. The role of co-morbidity as a predictor of outcome has 
been confirmed in other studies.'·11 In the present study, 
although co-morbidity was a predictor of poor outcome (Table 
1), this association was lost on multivariate analysis. 
2. It is surprising that age, like co-morbidity, was a predictor 
of outcome on bivariate but not on multivariate analysis. 
Advanced age has been associated with adverse outcome in 
many other studies. The findings of this study were similar to 
findings of some previous studies that identified low-risk 
patients with UGIB.' The lack of association after adjustment in 
the multivariate model indicates that in this sample, 
haemoglobin greater than 10 g/dl and the absence of melaena 
or syncope were associated with a younger age and better 
predicted outcome. 
3. Current intake of salicylates/NSAIDs was associated with 
an increased risk of peptic ulcer disease at endoscopy (RR 1.79, 
95% CI: 1.33- 2.40, p < 0.001) but was not significantly 
associated with outcome (Table 1). The use of these drugs has 
been associated with increased risk of peptic ulcer occurrence, 
ulcer complication (haemorrhage or perforation) and deathY 
Case control studies have found the increased risk of UGIB 
in patients taking NSAIDs to have a linear dose-response 
relationship." The correlation between risk of peptic ulcer 
disease and dosage was not explored in this study. The 
inclusion of patients taking minimal doses of NSAIDs could 
have impacted on its association with outcome. 
4. On bivariate analysis, presentation with haematemesis 
alone was associated with good outcome, while presentation 
with melaena alone was associated with poor outcome (Table 
I). This is unlike findings in most studies where haematemesis 
is associated with an adverse outcome.'· 13 The difficulty in 
comparing these studies with our study is that these studies 
included patients with varices who tend to present with 
haematemesis and are at high risk of a poor outcome. The 
other factor is that endpoints differ in different studies. The 
perceived need for blood transfusion as part of the outcome 
measures was included because of the perceived lack of 
expertise required for its administration at primary health care 
centres. We hypothesise that patients presenting with melaena 
alone may present late to hospital, as the bleeding is less brisk 
April 2003, Vol. 93, No. 4 SAMJ 
and less alarming. Therefore, they may present with much 
lower haemoglobin levels and require blood transfusion. 
5. Syncope is correlated with rapidity of blood loss. This 
variable has been incorporated as a predictor of outcome in 
very few studies. Those studies that included syncope as a 
predictor variable found it not to be a predictor of mortality.'·' 
Nevertheless, we cannot compare our findings with these 
studies, as their endpoint was mortality. In the American 
Society for Gastrointestinal Endoscopy survey,' syncope was 
associated with blood transfusion of more than five units. 
6. Haemoglobin, pulse and SBP are all measures of severity 
of the bleed. These variables have been used in many studies 
as predictors of outcome. On bivariate analysis, using inter-
nationally accepted cut-off levels for low risk of adverse 
outcome/' haemoglobin greater than 10 g/ dl, pulse rate less 
than 100 beats/minute and SBP greater than 100 mmHg were 
significantly associated with a good outcome. However, on 
multivariate analysis, pulse rate and blood pressure lost 
statistical significance. This is probably due to the association 
between pulse rate, blood pressure levels and haemoglobin 
value that was adjusted for in the multivariate modeL 
On multiple logistical regression analysis, in the final model, 
absence of melaena, absence of syncope and haemoglobin 
greater than 10 g/dl were the predictors of good outcome 
(Table III). A combination of all three variables significantly 
improved the association. The improved specificity, predictive 
values and LRs of the combined variables demonstrate this. 
Increasing the number of variables in the model (results not 
shown) did not improve its prediction of the outcome, and 
sensitivity decreased further, making the prediction rule 
worthless in selecting anyone for management without urgent 
endoscopy. 
The specificity for the predictor model of 98% and 95% CI of 
95 - 100% meet our predetermined requirement that a 
predictive tool should not have specificity of less than 95%. 
Of the 200 patients in the study, 30 (15%) satisfied the 
prediction rule (haemoglobin greater than 10 g/ dl, no melaena 
and no syncope). These patients would have been sent home 
without undergoing urgent endoscopy. However, 3 had been 
misclassified as they had a poor outcome. These 3 patients, 
who were false-positives according to the test criteria, required 
sclerotherapy to control haemorrhage. They did not have blood 
transfusion or surgery and were alive at 1 month. The clinical 
implications of these findings are that the test would result in a 
moderate impact on the reduction of unnecessary endoscopies 
(15% of admissions) with 5% or less of the patients with poor ~ 
outcome being sent home without urgent endoscopy. 
The prediction rule could be easily applied even in poorly 
resourced health centres, as it does not involve sophisticated 
equipment. It should be noted that these criteria help identify 
those who will get better anyway, regardless of endoscopy. It 
does not necessarily identify those who do not require 
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endoscopy for diagnostic purposes. 
However, a clinical decision rule is 'data driven' in that it is 
derived from a specific sample of patients. The test may not 
perform as well in different populations and therefore needs to 
be validated.15 Patients included in the study are not 
representative of our general population. Patients presenting to 
private hospitals with UGIB may be different at presentation 
from the study population in that they may present earlier or 
might have different degrees of exposure to risk factors for 
UGIB. Their outcome may differ due to different management 
strategies such as transfusion practices. For this reason, a 
validation study is required before the decision rule is 
considered for application in clinical practice. 
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